Skip to content

Drug interactions

Apalutamide + Linagliptin

Severity: Moderate

Apalutamide and Linagliptin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Linagliptin is mostly eliminated unchanged, with limited CYP3A4 metabolism, but it is a P-gp substrate. Strong inducers such as apalutamide can lower its exposure and reduce glucose-lowering effect.

What this interaction means in plain words

Apalutamide and Linagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Apalutamide belongs to Endocrine; Linagliptin belongs to Endocrine.

Evidence level: Moderate

Why it happens

Apalutamide induces CYP3A4 and P-glycoprotein, lowering linagliptin exposure.

What to do

Monitor glucose and HbA1c, and consider an alternative DPP-4 inhibitor or additional therapy if control is lost.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Apalutamide with Linagliptin?

MediHelp rates the interaction as moderate. Apalutamide and Linagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Linagliptin is mostly eliminated unchanged, with limited CYP3A4 metabolism, but it is a P-gp substrate. Strong inducers such as apalutamide can lower its exposure and reduce glucose-lowering effect.

How serious is the interaction between Apalutamide and Linagliptin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose and HbA1c, and consider an alternative DPP-4 inhibitor or additional therapy if control is lost.

What other medicines interact with Linagliptin?

MediHelp also lists interactions of Linagliptin with, for example, Alogliptin-pioglitazone, Amlodipine-benazepril, Amobarbital. The full list is on the Linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in